SCHEMBL16135243

SCHEMBL16135243

O=C(C(=O)N1CCCC(c2ccccc2)CC1)c1c[nH]c2c(-n3ccnn3)ncc(F)c12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C8 P10632 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2B6 P20813 1/20 0.40
CYP2C19 P33261 1/20 0.40
KCNH2 Q12809 1/20 0.40
IDO1 P14902 2/20 0.35
KDM4C Q9H3R0 2/20 0.35
KDM5A P29375 1/20 0.35
KDM5B Q9UGL1 1/20 0.35
KDM6B O15054 1/20 0.35
TPSAB1 Q15661 1/20 0.35
HCRTR1 O43613 1/20 0.35
HCRTR2 O43614 1/20 0.35
POLB P06746 1/20 0.35
HSD11B1 P28845 1/20 0.34
AVPR1A P37288 1/20 0.34
GABRA1 P14867 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16135264 0.94 CYP3A4 (0.39) CYP3A4CYP2C9CYP1A2CYP2C8CYP2D6
SCHEMBL16135261 0.94 CYP3A4 (0.40) CYP3A4CYP2C9CYP1A2CYP2C8CYP2D6
SCHEMBL13117259 0.88 CYP3A4 (0.39) CYP3A4CYP2C9CYP1A2CYP2C8CYP2D6
SCHEMBL16135262 0.87 BTK (0.39) CYP3A4CYP2C9CYP1A2CYP2C8CYP2D6
SCHEMBL16135269 0.87 PROKR1 (0.41)
SCHEMBL13116854 0.86 CYP3A4 (0.40) CYP3A4CYP2C9CYP1A2CYP2C8CYP2D6
SCHEMBL13117258 0.86 CYP3A4 (0.39) CYP3A4CYP2C9CYP1A2CYP2C8CYP2D6
SCHEMBL13117193 0.85 CYP3A4 (0.39) CYP3A4CYP2C9CYP1A2CYP2C8CYP2D6
SCHEMBL13116857 0.85 CYP3A4 (0.40) CYP3A4CYP2C9CYP1A2CYP2C8CYP2D6
SCHEMBL13116885 0.85 MAPT (0.38) CYP3A4CYP2C9CYP1A2CYP2C8CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2978763-B1 2-KETO AMIDE DERIVATIVES AS HIV ATTACHMENT INHIBITORS VIIV HEALTHCARE UK (NO 5) LTD (GB) 2018-03-07 EP disclosed
US-9586957-B2 2-keto amide derivatives as HIV attachment inhibitors VIIV Healthcare UK (No.5) Limited (GB) 2017-03-07 US disclosed
US-9586957-B2 2-keto amide derivatives as HIV attachment inhibitors VIIV Healthcare UK (No.5) Limited (GB) 2017-03-07 US disclosed
WO-2014160692-A1 2-KETO AMIDE DERIVATIVES AS HIV ATTACHMENT INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2014-10-02 WO disclosed